Skip to Main Content

Paper Details

Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor.
J Med Chem
9
2021
Author NameAffiliation
David E TimmLilly Research Laboratories
  • 1 - 1

Datasets

Release 1.2